PRO Therapeutics
PrivateLast Round
Seed
Dec 5, 2024
Total Funding Raised
$1.8M
Company Overview
PRO Therapeutics, LLC is a regenerative medicine company that develops and commercializes tissue-engineered grafts for soft tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PRO Therapeutics Comparables
Compare PRO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tetrous | 85% | |
| Atreon Orthopedics | 82% | |
| Zimmer Biomet | 77% |
PRO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2024 | ||||
| Grant | Jul 17, 2023 |
PRO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Partnerships | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 1194% MoM, from 33 to 427.
- Dec 5, 2024
Seed round raised with Innovation Partnerships participating.
PRO Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PRO Therapeutics's valuation, stock price, and market status.
Is PRO Therapeutics a public or private company?
PRO Therapeutics is a private company.
What is the current stock price of PRO Therapeutics?
PRO Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is PRO Therapeutics worth (valuation)?
Valuation information for PRO Therapeutics is not publicly available.
Can I buy PRO Therapeutics stock?
PRO Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PRO Therapeutics's last funding round?
PRO Therapeutics's most recent funding round was Seed on December 5, 2024.
Who are the main investors in PRO Therapeutics?
Key investors in PRO Therapeutics include National Institutes of Health (NIH).
Will PRO Therapeutics IPO soon?
No public IPO plans have been announced for PRO Therapeutics.
How can I track PRO Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PRO Therapeutics's secondary market activity and sign up for updates.